Skip to main content
The British Journal of Surgery logoLink to The British Journal of Surgery
. 2021 Aug 17;108(11):e361–e363. doi: 10.1093/bjs/znab280

Willingness to undergo antibiotic treatment of acute appendicitis based on risk of treatment failure

J E Rosen 1,2,, N Agrawal 3,4, D R Flum 5,6, J M Liao 7,8
PMCID: PMC9565954  NIHMSID: NIHMS1788118  PMID: 34401894

Abstract

A randomized survey of 1257 respondents was used to assess willingness to undergo antibiotic treatment of appendicitis with different quoted risks of treatment failure requiring appendicectomy. Overall, 1045 respondents (83.1 per cent) were willing to try antibiotics. Even at a quoted 60 per cent risk of failure, 75 per cent of respondents were willing to attempt antibiotic treatment.


Dear Editor,

The COVID-19 pandemic has led to increased adoption of non-operative management strategies for acute appendicitis1. Despite mounting evidence for their efficacy and safety2, surgeons may still hesitate to recommend antibiotics owing to concerns about high treatment failure risk and eventual appendicectomy (up to 30 per cent at 1 year)3,4. It is unknown how that risk, and the uncertainty around it, influences patients’ appendicitis decision-making.

A survey was undertaken of American adults recruited via Amazon Mechanical Turk in April 2021. The survey described antibiotics as non-operative appendicitis treatment and the probability of treatment failure within 3 months (need for appendicectomy), framed both negatively (chance of needing surgery) and positively (chance of avoiding surgery). Respondents were randomized to 1 of 14 arms varying in how treatment failure risk was described: seven arms reported risks of 10, 15, 20, 30, 40, 50, and 60 per cent; seven analogous arms reported these point estimates with the addition of a range (+/− 4 per cent). The primary outcome was willingness to try antibiotic treatment and the secondary outcome was perceived accuracy and trust in the information provided, measured on a five-point scale5. American Association for Public Reporting of Opinion Research reporting guidelines were followed.

After quality checks (87 of 1429 removed) and exclusion of those who had appendicitis previously (85 of 1342 removed), the sample consisted of 1257 adults. Sociodemographic characteristics were balanced across survey arms. Few (115 of 1257, 9.1 per cent ) were aware that antibiotics could be used to treat appendicitis before taking the survey. Most respondents (1045 of 1257, 83.1 per cent) were willing to try antibiotic treatment, with higher risks of treatment failure resulting in moderately lower willingness (Table 1). Among those who would try antibiotics, over half (599 of 1045, 57.3 per cent) were willing regardless of the risk of treatment failure, whereas, on average, the remaining respondents were willing to try until the treatment failure risk reached a mean(s.d.) of 53.6(23.0) per cent. Male sex and gender identity, increased perceived accuracy of information, and increased trust in the data were associated with willingness to try antibiotics.

Table 1.

Factors associated with willingness to try non-operative management of appendicitis

Overall Not willing to try non-operative management Willing to try non-operative management P
(n = 1257) (n = 212) (n = 1045)
Risk of treatment failure (%) 0.001
 10 92 10 (11) 82 (89)
 15 85 11 (13) 74 (87)
 20 86 17 (10) 69 (80)
 30 95 16 (17) 79 (83)
 40 93 20 (22) 73 (78)
 50 88 18 (20) 70 (80)
 60 92 23 (25) 69 (75)
 10 (6–14) 89 7 (8) 82 (92)
 15 (11–19) 94 10 (11) 84 (89)
 20 (16–24) 88 7 (8) 81 (92)
 30 (26–34) 85 11 (13) 74 (87)
 40 (36–44) 93 18 (19) 75 (81)
 50 (46–54) 87 19 (22) 68 (78)
 60 (56–64) 90 25 (28) 65 (72)
Age (years)* 37.37(12.38) 37.46(12.53) 37.36(12.35) 0.910
Sex 0.001
 F 752 150 (19.9) 602 (80.1)
 M 501 62 (12.4) 439 (87.6)
 Prefer not to say 4 0 (0) 4 (100)
Gender identity 0.028
 Woman 735 147 (20.0) 588 (80.0)
 Man 498 63 (12.7) 435 (87.3)
 Genderqueer/gender non-conforming 11 2 (18) 9 (82)
 Trans male/trans man 5 0 (0) 5 (100)
 Prefer not to say 4 0 (0) 4 (100)
 Trans female/trans woman 2 0 (0) 2 (100)
 Different identity 2 0 (0) 2 (100)
Racial identity 0.748
 Black 125 24 (19.2) 101 (80.8)
 East Asian 75 11 (15) 64 (85)
 Multiple identities 56 12 (21) 44 (79)
 Other Specified Identity 29 7 (24) 22 (76)
 South Asian 43 7 (16) 36 (84)
 Unknown 12 1 (8) 11 (92)
 White 917 150 (16.4) 767 (83.6)
Ethnicity 0.212
 Hispanic/Latino/Latinx 105 24 (22.9) 81 (77.1)
 Non-Hispanic/Latino/Latinx 1095 181 (16.5) 914 (83.5)
 Prefer not to say 27 2 (7) 25 (93)
 Prefer to write it down 30 5 (17) 25 (83)
Education level 0.369
 Some high school 4 1 (25) 3 (75)
 High school/GED 112 14 (12.5) 98 (87.5)
 Some college 268 55 (20.5) 213 (79.5)
 2-year college degree 134 24 (17.9) 110 (82.1)
 4-year college degree 499 76 (15.2) 423 (84.8)
 Graduate degree 235 42 (17.9) 193 (82.1)
 Unknown 5 0 (0) 5 (100)
Insurance 0.726
 Employer-provided 649 111 (17.1) 538 (82.9)
 Private 179 36 (20.1) 143 (79.9)
 Other government 48 6 (12) 42 (88)
 Medicaid 131 21 (16.0) 110 (84.0)
 Medicare 96 17 (18) 79 (82)
 Not insured 124 18 (14.5) 106 (85.5)
 Other 30 3 (10) 27 (90)
Employment status 0.881
 Employed full-time (≥ 40 h/week) 661 107 (16.2) 554 (83.8)
 Employed part-time (< 40 h/week) 144 21 (14.6) 123 (85.4)
 Self-employed 124 22 (17.7) 102 (82.3)
 Retired 59 12 (20) 47 (80)
 Student 80 17 (21) 63 (79)
 Unemployed (looking for work) 97 17 (17) 80 (83)
 Unemployed (not looking for work) 80 13 (16) 67 (84)
 Prefer not to say 12 3 (25) 9 (75)
Annual household income(euros) 0.446
 < 21 076 176 27 (15.3) 149 (84.7)
 21 077–42 150 326 60 (18.4) 266 (81.6)
 42 151–63 224 248 45 (18.1) 203 (81.9)
 63 225–84 299 203 39 (19.2) 164 (80.8)
 >84 299 262 34 (13.0) 228 (87.0)
 Prefer not to say 42 7 (17) 35 (83)
Perceived information accuracy* 3.40(0.98) 3.01(1.10) 3.48(0.94) < 0.001
Trust in information given*§ 3.42(1.00) 2.87(1.09) 3.53(0.94) < 0.001

Values in parentheses are percentages unless indicated otherwise; *values are mean(s.d.). Range. Scale from 1 to 5, with 5 being highest perceived accuracy. §Scale from 1 to 5, with 5 being greatest trust. GED = General Educational Development Test, t-test for continuous variables and chi-squared test for categorical variables test.

The proportion of individuals willing to try antibiotics was generally higher when ranges were provided alongside the point estimate for treatment failure risks (Table 1). Perceived accuracy (mean(s.d.) score 3.3(1.0) versus 3.5(1.0); P < 0.001) and trust in the information (mean score 3.3(1.0) versus 3.5(1.0); P = 0.001) was also greater in arms including ranges.

Increasing evidence of the efficacy and safety of non-operative treatment for uncomplicated acute appendicitis has led to the recognition that this treatment decision is value- and preference- dependent, and must be made jointly with patients3. Although surgeons commonly report a threshold for risk of treatment failure that makes it too high to be worth trying4, this study found that over 70 per cent of patients were willing to try antibiotics for even a 40 per cent chance of avoiding surgery. This suggests a disconnect between the ways clinicians and patients conceptualize risk and benefit. An additional observation is that surgeons may affect patients’ perceived accuracy of and trust in treatment information by providing uncertainty information. Providing ranges increased trust and accuracy perceptions, which were in turn associated with greater willingness to try antibiotics.

Study limitations include use of a sample that may differ from patients experiencing appendicitis, and a focus on one aspect of appendicitis treatment, which the authors felt was the most likely to have a misalignment between patient and surgeon values. Nonetheless, these findings provide what is to the authors’ knowledge the first evidence to date about a clinically salient dynamic—individuals’ willingness to try treatments that surgeons may consider too high risk. This is a critical area for future work and strong shared decision-making between surgeons and patients.

Acknowledgements

This study was not preregistered in an independent institutional registry. J.M.L. reports personal fees from Kaiser Permanente Washington Health Research Institute, and honoraria from Wolters Kluwer, the journal Clinical Pathways, and the American College of Physicians, all outside of this submitted work .

Funding

J.E.R. is supported by a training grant from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (T32DK070555). This work was funded in part by a generous gift from Marty and Linda Ellison.

Disclosure. The authors declare no conflict of interest.

Contributor Information

J E Rosen, Surgical Outcomes Research Center, Department of Surgery, University of Washington, Seattle, Washington, USA; Decision Science Group, Seattle, Washington, USA.

N Agrawal, Decision Science Group, Seattle, Washington, USA; Foster School of Business, University of Washington, Seattle, Washington, USA.

D R Flum, Surgical Outcomes Research Center, Department of Surgery, University of Washington, Seattle, Washington, USA; Decision Science Group, Seattle, Washington, USA.

J M Liao, Decision Science Group, Seattle, Washington, USA; Department of Medicine, University of Washington, Seattle, Washington, USA.

References

  • 1. Ielpo B, Podda M, Pellino G, Pata F, Caruso R, Gravante G  et al.  Global attitudes in the management of acute appendicitis during COVID‐19 pandemic: ACIE Appy Study. Br J Surg  2020;108:717–726. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.CODA Collaborative, Flum DR, Davidson GH, Monsell SE, Shapiro NI, Odom SR  et al.  A randomized trial comparing antibiotics with appendectomy for appendicitis. New Engl J Med  2020;383:1907–1919. [DOI] [PubMed] [Google Scholar]
  • 3. Sallinen V, Akl EA, You JJ, Agarwal A, Shoucair S, Vandvik PO  et al.  Meta‐analysis of antibiotics versus appendicectomy for non‐perforated acute appendicitis. Br J Surg  2016;103:656–667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. O’Leary DP, Walsh SM, Bolger J, Baban C, Humphreys H, O’Grady S  et al.  A randomised clinical trial evaluating the efficacy and quality of life of antibiotic only treatment of acute uncomplicated appendicitis: results of the COMMA trial. Ann Surg  2021;274:240–247. [DOI] [PubMed] [Google Scholar]
  • 5. Han PKJ, Klein WMP, Lehman T, Killam B, Massett H, Freedman AN.  Communication of uncertainty regarding individualized cancer risk estimates. Med Decis Making  2011;31:354–366. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The British Journal of Surgery are provided here courtesy of Oxford University Press

RESOURCES